Bridging Basic and Translational Science in Cardiovascular Disease

摘要 该提案要求NHLBI支持基础设施理事会提出的科学会议。 美国心脏协会（AHA）心血管科学（BCVS）。这次会议已成为“去 为基础和转化心血管科学提供机会， 新的调查人员介绍他们的工作，并获得建设性的反馈。2022年的会议 这是连续第十七届年会。BCVS科学会议的资金来源 国家心脏，肺和血液研究所（NHLBI）在过去16年中有15年得到了保护。这些bcv 夏季会议的主题是“桥接心血管疾病的基础和转化科学”。在 2021年，我们的虚拟会议有来自世界各地的700多名调查人员参加。我们感觉到 我们的社区迫切需要在2022年举行一次面对面的会议，以帮助促进职业发展， 为年轻的研究人员提供网络机会。会议定于2022年7月25日至28日举行，将开始 从周一到周四我们预计我们也将能够举行面对面会议 为那些无法亲自参加的人提供了虚拟内容（混合会议）。会议将突出 基础心血管研究与心血管健康和疾病的影响。会有 约18次排定的会议，包括既有调查员也有新的调查员。的 Leslie Leinwand博士将作主旨发言。有一个专门的会议，为那些在早期的职业生涯 相位我们将举办网络特别会议，包括与期刊编辑和工作人员的互动。我们 还将包括妇女参与科学网络活动。在每一步，我们都专注于多样性和包容性 推广最好的心血管科学这项R13提案旨在为年轻人提供支持， 调查员能够以口头或海报形式作为发言者参加会议。的 主要组织者是皮拉尔阿尔凯德博士和苏曼思帕布。项目组（12名成员） 包括过去的项目联合主席和来自美国和国际的多元化领导层， BCVS涵盖的许多学科。AHA将继续提供其出色的行政管理 配备专职工作人员，为会议提供后勤支助。我们完全期望这个团队能够协调 2022年BCVS大会

ABSTRACT This proposal requests NHLBI support for the Scientific Sessions meeting presented by the Council on Basic Cardiovascular Sciences (BCVS) of the American Heart Association (AHA). This meeting has become the “go to” meeting for basic and translational cardiovascular sciences by providing opportunities for established and emerging investigators to present their work and receive constructive feedback. The meeting in 2022 represents the seventeenth consecutive annual conference. Funding for BCVS Scientific Sessions from National Heart, Lung and Blood Institute (NHLBI) has been secured for 15 of the last 16 years. The BCVS summer conference is entitled “Bridging Basic and Translational Science in Cardiovascular Disease”. In 2021, our virtual conference was attended by more than 700 investigators from around the world. We sense an urgent need for our community to hold an in-person meeting in 2022 to help facilitate the careers and networking opportunities for young investigators. The meeting is scheduled for July 25-28, 2022 and will begin on a Monday and run through Thursday. We expect that we will be able to hold an in-person meeting as well has have virtual content (hybrid meeting) for those who cannot attend in-person. The conference will highlight basic cardiovascular research with implications for cardiovascular health and disease. There will be approximately 18 scheduled sessions that include a mix of established and emerging investigators. The keynote address will be given by Dr. Leslie Leinwand. There is a specific session for those in the early career phase. We will host special sessions for networking including interactions with journal editors and staff. We will also include the Women in Science networking event. At every step, we focus on diversity and inclusivity to promote the very best cardiovascular science. This R13 proposal is designed to provide support to young investigators to enable their participation in the meeting as presenters either in oral or poster format. The primary organizers are Drs. Pilar Alcaide and Sumanth Prabhu. The Program Committee (12 members) includes the past program co- chairs and a diverse leadership (both US and international) drawn from the many disciplines encompassed by BCVS. The AHA will continue to provide its outstanding administrative support with dedicated staff for the logistics of the conference. We fully anticipate that this team will coordinate an exceptional 2022 BCVS conference.